Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving HealthEquity, Inc and its officers or directors [1] Financial Performance - On March 18, 2025, HealthEquity reported its financial results for the fourth quarter and fiscal year ending January 31, 2025, with earnings per share that fell short of analyst expectations [3] - The company provided weak guidance for the fiscal year ending January 31, 2026, indicating potential challenges ahead [3] Stock Market Reaction - Following the announcement of disappointing earnings and guidance, HealthEquity's stock price dropped by $17.35 per share, or 17.07%, closing at $84.32 per share on March 19, 2025 [3] Cybersecurity Concerns - HealthEquity's management cited "excess service expense" due to increased cyber threats and fraud attacks, which have been attributed to sophisticated techniques employed by malicious actors [3]

The HSA leader was recognized for its remote-first flexibility and mental health resources, marking its fourth year on the list DRAPER, Utah, April 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation's largest health savings account (HSA) administrator, today announced it has been named a USA Today Top Workplace for 2025, ranking 23 nationwide for companies with more than 2,500 employees. This is HealthEquity's fourth consecutive year on the coveted list, and it is the ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of HealthEquity, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Legal Action and Investor Rights - Shareholders who purchased HealthEquity securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2]. - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to HealthEquity [2]. Group 2: Company Performance and Market Reaction - HealthEquity's stock price fell by 17% on March 19, 2025, following an article that reported the company's missed profit estimates and weak guidance due to increased criminal activity targeting the firm [3]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4].

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. SO WHAT: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr ...

It has been about a month since the last earnings report for HealthEquity (HQY) . Shares have lost about 2.2% in that time frame, outperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is HealthEquity due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It t ...

HealthEquity (HQY) has faced a challenging start to 2025, with the stock plunging more than 13.1% year to date compared with the industry’s 1.5% and S&P 500 Index’s 9.2% decline, respectively. This downturn comes on the heels of the company's fiscal fourth-quarter earnings call, wherein management informed about the escalating cyber threats and fraud-related expenses, along with increased operational costs. Additionally, the ongoing global tariff war has put added pressure on the company, potentially impact ...

DRAPER, Utah, April 15, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation’s largest Health Savings Account (HSA) administrator, has been recognized by the Business Intelligence Group for its Expedited Claims AI system at the 2025 Artificial Intelligence Excellence Awards. The award honors outstanding organizations, products, and individuals who have harnessed the power of AI for good to solve real-world problems. HealthEquity won awards for “Innovative AI Products” in th ...

Core Insights - HealthEquity, Inc. has been recognized for its Expedited Claims AI system at the 2025 Artificial Intelligence Excellence Awards, highlighting its innovative use of AI in healthcare [1][2][6] Company Overview - HealthEquity is the largest Health Savings Account (HSA) administrator in the U.S., managing over 17 million accounts and partnering with employers and benefits advisors to enhance healthcare consumer experiences [7] Product Innovation - The Expedited Claims system streamlines the healthcare claims process, allowing users to submit claims quickly via the EZ Receipts mobile app, often in under a minute, with over 50% of claims processed in less than two minutes [3] - Members using Expedited Claims save an average of 70% of the time typically spent on claims entry and processing [3] - Since its implementation, member satisfaction has increased by 18%, with 70% of members reporting satisfaction or high satisfaction with their reimbursement experience [4] AI Development - HealthEquity has developed multiple AI-powered products, including HSAnswers, an AI knowledgebase for HSA-related inquiries, and HealthEquity Assist™, a suite of tools designed to help members navigate benefit options and spending [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of HealthEquity, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased HealthEquity securities [2] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] Group 2: Company Performance and Market Reaction - HealthEquity's shares fell 17% on March 19, 2025, after an article reported that the company missed profit estimates and provided weak guidance due to increased criminal activity targeting the firm [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered over $438 million for investors in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of HealthEquity, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased HealthEquity securities [2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Company Performance and Market Reaction - HealthEquity's stock price fell 17% on March 19, 2025, following an article that reported the company missed profit estimates and provided weak guidance due to increased criminal activity targeting the firm [3].